A recent study reported that high systemic concentrations of CCL2 were positively associated with OS in melanoma patients with in transit metastasis treated with melphalan (62), possibly because of the capability of this chemokine to attract both T lymphocytes and monocytes within melanoma (63). This evidence concerns the gene CCL2 and melanoma.